Gene · 407055
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The potential of using non-coding RNAs in forensic science applications. | Forensic Sci Res | 2023 | 37621455 | PubTator, text mining | PubMed |
| MicroRNA expression changes in the development of rotator cuff tendon injuries. | JSES Rev Rep Tech | 2023 | 37588508 | PubTator, text mining | PubMed |
| Serum lncRNA THRIL predicts benign and malignant pulmonary nodules and promotes the progression of pulmonary malignancies. | BMC Cancer | 2023 | 37582734 | PubTator, text mining | PubMed |
| The regulation of lncRNAs and miRNAs in SARS-CoV-2 infection. | Front Cell Dev Biol | 2023 | 37576600 | PubTator, text mining | PubMed |
| Epigenetic Factors and ncRNAs in Testicular Cancer. | Int J Mol Sci | 2023 | 37569569 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs in Venous Thromboembolism: Where Do We Stand? | Int J Mol Sci | 2023 | 37569483 | PubTator, text mining | PubMed |
| Dysregulated miRNA and mRNA Expression Affect Overlapping Pathways in a Huntington's Disease Model. | Int J Mol Sci | 2023 | 37569316 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications. | Cancers (Basel) | 2023 | 37568568 | PubTator, text mining | PubMed |
Moderate evidence exists for four microRNAs as potential biomarkers for tendinopathies and degenerative tendon ruptures at the upper extremity in elderly patients: conclusion of a systematic review with best-evidence synthesis. | J Exp Orthop | 2023 | 37563331 | PubTator, text mining | PubMed |
| Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration. | J Biomed Sci | 2023 | 37550658 | PubTator, text mining | PubMed |
| Prognostic implication of downregulated exosomal miRNAs in patients with sepsis: a cross-sectional study with bioinformatics analysis. | J Intensive Care | 2023 | 37537685 | PubTator, text mining | PubMed |
| Exosomal circCNOT6L Regulates Astrocyte Apoptotic Signals Induced by Hypoxia Exposure Through miR99a-5p/SERPINE1 and Alleviates Ischemic Stroke Injury. | Mol Neurobiol | 2023 | 37531026 | PubTator, text mining | PubMed |
| Circulating miRNAs as a Tool for Early Diagnosis of Endometrial Cancer-Implications for the Fertility-Sparing Process: Clinical, Biological, and Legal Aspects. | Int J Mol Sci | 2023 | 37511115 | PubTator, text mining | PubMed |
| MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer. | Cells | 2023 | 37508580 | PubTator, text mining | PubMed |
| RNA-Based Liquid Biopsy in Head and Neck Cancer. | Cells | 2023 | 37508579 | PubTator, text mining | PubMed |
| The Molecular Pathogenesis of Tumor-Suppressive miR-486-5p and miR-486-3p Target Genes: GINS4 Facilitates Aggressiveness in Lung Adenocarcinoma. | Cells | 2023 | 37508549 | PubTator, text mining | PubMed |
| MicroRNAs in Juvenile Idiopathic Arthritis: State of the Art and Future Perspectives. | Biology (Basel) | 2023 | 37508421 | PubTator, text mining | PubMed |
| Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early-stage luminal breast cancer. | Mol Oncol | 2023 | 37491786 | PubTator, text mining | PubMed |
| Gain of chromosome 21 increases the propensity for P2RY8::CRLF2 acute lymphoblastic leukemia via increased HMGN1 expression. | Front Oncol | 2023 | 37483494 | PubTator, text mining | PubMed |
| Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications. | Front Oncol | 2023 | 37476370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407055/papers?page=8